We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
OSLO | OncoSil Medical Ltd | 0.002 | 0.001 | 100.00% | 526,135 | 1 |
TSOOA | Tesoro Gold Ltd | 0.01 | 0.005 | 100.00% | 210,000 | 2 |
ESROB | Estrella Resources Limited | 0.002 | 0.001 | 100.00% | 300,000 | 1 |
VRXRA | VRX Silica Limited | 0.002 | 0.001 | 100.00% | 73,124 | 3 |
NNGO | Nexion Group Ltd | 0.002 | 0.001 | 100.00% | 569,841 | 2 |
AEVO | Avenira Limited | 0.002 | 0.001 | 100.00% | 600,000 | 2 |
GMNO | Gold Mountain Limited | 0.002 | 0.001 | 100.00% | 250,500 | 1 |
EXLO | Elixinol Wellness Limited | 0.0015 | 0.0005 | 50.00% | 2,445,450 | 2 |
BLZ | Blaze Minerals Ltd | 0.006 | 0.002 | 50.00% | 3,190,427 | 18 |
MRQ | MRG Metals Ltd | 0.0015 | 0.0005 | 50.00% | 8,833,334 | 5 |
T92O | Terra Uranium Ltd | 0.02 | 0.005 | 33.33% | 7,500 | 1 |
NEW YORK, April 17, 2024 /PRNewswire/ -- Ace Global Business Acquisition Limited (NASDAQ: ACBA) (the "Company"), a special purpose acquisition company, announced today that Ace Global Investment Limited, the Company's initial public offering sponsor (the "Sponsor"), has deposited into the Company's trust account (the "Trust Account") an aggregate of $30,000 (representing the lesser of (i) $30,000 and (ii) an aggregate amount equal to $0.033 multiplied by the number of issued and outstanding Company ordinary shares issued in the Company's initial public offering that has not been redeemed), in order to extend the period of time the Company has to complete ...
NEW YORK, April 17, 2024 /PRNewswire/ -- Ace Global Business Acquisition Limited (NASDAQ: ACBA) (the "Company"), a special purpose acquisition company, announced today that Ace Global Investment Limited, the Company's initial public offering sponsor (the "Sponsor"), has deposited into the Company's trust account (the "Trust Account") an aggregate of $30,000 (representing the lesser of (i) $30,000 and (ii) an aggregate amount equal to $0.033 multiplied by the number of issued and outstanding Company ordinary shares issued in the Company's initial public offering that has not been redeemed), in order to extend the period of time the Company has to complete ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on April 10, 2024, the Compensation Committee of Acadia’s Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common stock and 12,739 restricted stock units (“RSUs”) to six new employees under Acadia’s 2023 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).
TULSA, Okla., April 18, 2024 /PRNewswire/ -- AAON, Inc. (NASDAQ: AAON) ("AAON" or the "Company"), a provider of premier, configurable HVAC solutions that bring long-term value to customers and owners, announces that it has scheduled its quarterly conference call and webcast for Thursday, May 2, 2024, at 5:15 p.m. EDT to discuss first quarter 2024 financial results. The results will be released immediately after the market closes on that same day.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 64,199.99 | 689.82 | 1.09% | 1.26T | 8,902,717,002 |
ETH | Ethereum | 3,092.76 | 26.91 | 0.88% | 372.96B | 3,593,598,500 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 541,955,437 |
BNB | Binance Coin | 561.08 | 8.86 | 1.60% | 88.57B | 400,275,857 |
SOL | Solana | 144.75 | 2.67 | 1.88% | 64.13B | 2,707,211,707 |
STETH | stETH | 3,086.71 | 25.77 | 0.84% | 30.41B | 14,524,665 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 1,237,956,315 |
XRP | Ripple | 0.5068 | 0.0038 | 0.76% | 27.63B | 510,652,282 |
DOGE | Dogecoin | 0.15368 | 0.00132 | 0.87% | 22.07B | 791,748,141 |
TONCOIN | Wrapped TON Coin | 6.15 | -0.361323 | -5.55% | 21.42B | 595,408,707 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions